Structural aspects of signal transduction in B-cells

Critical Reviews in Immunology

Volumn 16, Issue 3, 1996, Pages 251-274

  Vihinen, Mauno ^a   Edvard Smith, C I ^b,c  

^a UNIVERSITY OF HELSINKI   (Finland)

^b KAROLINSKA INSTITUTE   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Btk; PH; protein kinases; SH2; SH3; signal transduction; TH; XLA

Indexed keywords

CYTOKINE RECEPTOR; IMMUNOGLOBULIN; PROTEIN KINASE; PROTEIN SERINE THREONINE KINASE; PROTEIN TYROSINE KINASE;

B LYMPHOCYTE; CELL MATURATION; GENE MUTATION; HUMAN; MOLECULAR MODEL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; X RAY CRYSTALLOGRAPHY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; B-LYMPHOCYTES; CELL DIFFERENTIATION; ENZYME PRECURSORS; GRB2 ADAPTOR PROTEIN; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MUTAGENESIS; PROTEIN-TYROSINE KINASES; PROTEINS; RECEPTORS, ANTIGEN, B-CELL; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES;

EID: 10344244510     PISSN: 10408401     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (254)

1. Alt, F. W., Bothwell, A. L. M., Knapp, M., Siden, E., Mather, E., Koshland, M., and Baltimore, D., Synthesis of secreted and membrane-bound immunoglobulin μ heavy chains is directed by mRNAs that differ at their 3′ ends, Cell, 20, 293, 1980.
2. Early, P., Rogers, J., Davis, M., Calame, K., Bond, M., Wall, R., and Hood, L., Two mRNAs can be produced from a single immunoglobulin μ gene by alternative RNA processing pathways, Cell, 20, 313, 1980.
3. Springer, T. A., Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm, Cell, 76, 301, 1994.
4. Vetrie, D., Vorechovsky, I., Sideras, P., Holland, J., Davies, A., Flinter, F., Hammarström, L., Kinnon, C., Levinsky, R., Bobrow, M., Smith, C. I. E., and Bentley, D. R., The gene involved in X-linked agammaglobulinemia is a member of the src family of protein-tyrosine kinases, Nature, 361, 226, 1993.
5. Tsukada, S., Saffran, D. C., Rawlings, D. J., Parolini, O., Allen, R. C., Klisak, I., Sparkes, R. S., Kubagawa, H., Mohandas, T., Quan, S., Belmont, J. W., Cooper, M. D., Conley, M. E., and Witte, O. N., Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammagiobulinemia, Cell, 72, 279, 1993.
6. Sideras, P. and Smith, C. I. E., Molecular and cellular aspects of X-linked agammaglobulinemia, Adv. Immunol., 59, 135, 1995.
7. Smith, C. I. E. and Notarangelo, D., Molecular basis for X-linked immunodeficiencies, Adv. Genet., 35, in press, 1996.
8. Georgopoulos, K., Bigby, M., Wang, J.-H., Molnar, A., Wu, P., Winandy, S., and Sharpe, A., The ikaros gene is required for the development of all lymphoid lineages, Cell, 79, 143, 1994.
9. Tsui, H. W., Siminovitch, K. A., de Souza, L., and Tsui, F. W. L., Motheaten and viable motheaten mice have mutations in the hematopoietic cell phosphatase gene, Nature Genet., 4, 124, 1993.
10. Shultz, L. D., Schweitzer, P. A., Rajan, T. V., Yi, T., Ihle, J. N., Matthews, R. J., Thomas M. L., and Beier, D., Mutations at the murine motheaten locus are within the hematopoietic cell protein tyrosine phosphatase (Hcph) gene, Cell, 73, 1445, 1993.
11. Kishihara, K., Penninger, J. Wallace V. A., Kündig, T. M., Kawai, K., Wakeham, A., Timms, E., Pfeffer, K., Ohashi, P. S., Thomas, M. L., Furlonger, C., Paige, C. J., and Mak, T. W., Normal B lymphocyte development but impaired T cell maturation in CD45-exon6 protein tyrosine phosphatase-deficient mice, Cell, 74, 143, 1993.
12. Pawson, T., Protein modules and signalling networks, Nature, 373, 573, 1995.
13. Cohen, G. B. Ren, R., and Baltimore D., Modular binding domains in signal transduction proteins, Cell, 80, 238, 1995.
14. Ehrlich, P., The Croonian lecture: on immunity, Proc. R. Soc. London (Biol.), 66, 424, 1900.
15. Raff, M. C., Steinberg, J., and Taylor, R., Immunoglobulin determinants on the surface of mouse lymphoid cells, Nature, 225, 553, 1970.
16. Hozumi, N. and Tonegawa, S., Evidence for somatic rearrangement of immunoglobulin genes coding for variable and constant regions, Proc. Natl. Acad. Sci. U.S.A., 73, 3628, 1976.
17. Tonegawa, S., Somatic generation of antibody diversity, Nature, 302, 575, 1983.
18. Hedrick, S. M., Cohen, D. I., Nielson, E. A., and Davis, M., Isolation of cDNA clones encoding T cell-specific membrane-associated proteins, Nature, 308, 149, 1984.
19. Yanagi, Y., Yoshika, Y., Leggett, K., Clark, S. P., Aleksander, I., and Mak, T. W., A human T cell-specific cDNA clone encodes a protein having extensive homology to immunoglobulin chains, Nature, 308, 145, 1984.
20. van Agthoven, A., Terhorst, C., Reinhert, C., and Schlossman, S. F., Characterization of T cell surface glycoproteins T1 and T3 present on all human peripheral T lymphocytes and functionally mature thymocytes, Eur. J. Immunol., 11, 18, 1981.
21. Sitia, R., Neuberger, M., and Milstein, C., Regulation of membrane IgM expression in secretory B cells: translational and post-translational events, EMBO J., 6, 3969, 1987.
22. Hombach, J., Sablitzky, F., Rajewsky, K., and Reth, M., Transfected plasmacytoma cells do not transport the membrane form of IgM to the cell surface, J. Exp. Med., 167, 652, 1988.
23. Hombach, J., Leclercq, L., Radbruch, A., Rajewsky, K., and Reth, M., A novel 34 kDa protein co-isolated with IgM molecule in surface IgM expressing cells, EMBO J., 7, 3451, 1988.
24. Hombach, J., Tsubata, T., Leclercq, L., Stappert, H., and Reth, M., Molecular components of the B cell antigen receptor complex of the IgM class. Nature, 343, 760, 1990.
25. Campbell, K. S. and Gambier, J. C., B-lymphocyte antigen receptors (mIg) are noncovalently associated with a disulfide-linked, inducibly phosphorylated glycoprotein complex, EMBO J., 9, 441, 1990.
26. Sakaguchi, N., Kashiwamura, S.-I., Kinoto, M., Thalmann, P., and Melchers, F., B lymphocyte lineage expression of inb-1, a gene with CD3-like structural properties, EMBO J., 7, 3457, 1988.
27. Hermanson, G. G., Eisenberg, D., Kincade, P. W., and Wall, R., A member of the immunoglobulin gene superfamily exclusively expressed on B-lineage cells, Proc. Natl. Acad. Sci. U.S.A., 85, 6890, 1988.
28. Reth, M., Antigen receptors on B lymphocytes Annu. Rev. Immunol., 10, 97, 1992
29. Reth M., Antigen receptor tail clue, Nature, 338, 383, 1989.
30. Gambier, J. C., Pleiman, C. M., and Clark, M. R., Signal transduction by the B cell antigen receptor and its coreceptors, Annu. Rev. Immunol., 12, 457, 1994.
31. Reth, M., The cell antigen receptor complex and coreceptors, Immunol. Today, 16, 310, 1995.
32. gag-fps Mol. Cell. Biol., 6, 4396, 1986.
33. Kong, G.-H., Bu, J.-Y., Kurosaki, T., Shaw, A. S., and Chan, A. C., Reconstitution of syk function by the ZAP-70 protein tyrosine kinase, Immunity, 2, 485, 1995.
34. Hatada, M. H., Lu, X., Laird, E. R., Green, J., Morgenstern, J. P., Lou, M., Marr, C. S., Phillips, T. B., Ram, M. K., Theriault, K., Zoller, M. J., and Karas, J. L., Molecular basis for the interaction of the protein tyrosine kinase ZAP-70 with the T-cell receptor, Nature, 377, 32, 1995.
35. Weiss, A., Zapping tandem SH2 domains, Nature, 377, 17, 1995.
36. Chan, A. C., Iwashima, M., Turck, C. W., and Weiss, A., ZAP-70: a 70 kDa protein-tyrosine kinase that associates with the TCR ζ chain, Cell, 71, 649, 1992.
37. Iwashima, M., Irving, B. A., van Oers, N. S. C., Chan, A. C., and Weiss, A., Sequential interactions of the TCR with two distinct cytoplasmic tyrosine kinases, Science, 263, 1136, 1994.
38. Shiue, L., Zoller, M. J., and Brugge, J. S., Syk is activated by phosphotyrosine-containing peptides representing the tyrosine-based activation motifs of the high-affinity receptor for IgE, J. Biol. Chem., 270, 10498, 1995.
39. Cheng, A. M., Rowley, B., Pao, W., Hayday, A., Bolen, J. B., and Pawson, T., The syk tyrosine kinase is required for mouse viability and B-cell development, Nature, 378, 303, 1995.
40. Turner, M., Mee, P. J., Costello, P. S., Williams, O., Price, A. A., Duddy, L. P., Durlong, M. T., Geahlen, R. L., and Tybulewics, L. J., Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk, Nature, 378, 298, 1995.
41. Negishi, I., Motoyama, N., Nakayama, K.-I., Nakayama, K., Senju, S., Hatakeyama, S., Zhang, Q., Chan, A. C., and Loh, D. Y., Essential role for ZAP-70 in both positive and negative selection of thymocytes, Nature, 376, 435, 1995.
42. + thymic selection in humans lacking Zap-70 kinase, Cell, 76, 947, 1994.
43. Elder, M. E., Lin, D., Clever, J., Chan, A. C., Hope, T. J., Weiss, A., and Parslow, T. G., Human severe combined immunodeficiency due to a defect in ZAP-70, a T cell tyrosine kinase, Science, 264, 1596, 1994.
44. Chan, A. C., Kadlecek, T. A., Elder, M. E., Filipovich, A. H., Kuo, W.-L., Iwashima, M., Parslow, T. G., and Weiss, A., ZAP-70 deficiency in an autosomal recessive form of severe combined immunodeficiency, Science, 264, 1599, 1994.
45. Minami, Y., Kono, T., Miyazaki, T., and Taniguchi, T., The IL-2 receptor complex: its structure, function, and target genes, Annu. Rev. Immunol., 11, 245, 1993.
46. Darnell, J. E., Kerr, I. M., and Stark, G. R., Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins, Science, 264, 1415, 1994.
47. Kishimoto, T., Taga, T., and Akira, S., Cytokine signal transduction, Cell, 76, 253, 1994.
48. Ihle, J. N. and Kerr, I. M., Jaks and stats in signaling by the cytokine receptor superfamily, Trends Genet., 11, 69, 1995.
49. Ihle, J. N., Witthuhn, B. A., Quell, F. W., Yamamoto, K., and Silvennoinen, O., Signaling through the hematopoietic cytokine receptors, Annu. Rev. Immunol., 13, 369, 1995.
50. Sugamura, K., Asao, H., Kondo, M., Tanaka, N., Ishii, N., Nakamura, M., and Takeshita, T., The common γ-chain for multiple cytokine receptors, Adv. Immunol., 59, 225, 1995.
51. Noguchi, M., Yi, H., Rosenblatt, H. M., Filipovich, A. H., Adelstein, S., Modi, W. S., McBride, O. W., and Leonard, W. J., Interleukin-2 receptor γ chain mutation results in X-linked severe combined immunodeficiency in humans, Cell, 73, 147, 1993.
52. c, Immunol. Rev., 138, 61, 1994.
53. Wilks, A. F., Two putative protein-tyrosine kinases identified by the application of the polymerase chain reaction, Proc. Natl. Acad. Sci. U.S.A., 86, 1603, 1989.
54. Firmbach-Kraft, I., Byers, M., Shows, T., Dalla-Favera, R., and Krolewski, J. J., Tyk2, prototype of a novel class of non-receptor tyrosine kinase genes, Oncogene, 5, 1329, 1990.
55. Wilks, A. F., Cloning members of protein-tyrosine kinase family using polymerase chain reaction, Method. Enzymol., 200, 533, 1991.
56. Macci, P. Villa, A., Giliani, S., Sacco, M. G., Frattini, A., Porta, F., Ugazio, A. G., Johnston, J. A., Candotti, F., O'Shea, J. J., Vezzoni, P., and Notarangelo, L. D., Mutations in the Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID), Nature, 377, 65, 1995.
57. Thomas, D. C., Gurniak, C. B., Tivol, E., Sharpe, A. H., and Berg, L. J., Defects in B lymphocyte maturation and T lymphocyte activation in mice lacking Jak3, Science, 270, 794, 1995.
58. Russel, S. M., Tayebi, N., Nakajima, H., Riedy, M. C., Roberts, J. L., Aman, M. J., Migone, T.-S., Noguchi, M., Markert, M. L., Buckley, R. H., Oshea, J. J., and Leonard, W. J., Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development, Science, 270, 797, 1995.
59. Nosaka, T., van Deursen, J. M. A., Tripp, R. A., Thierfelder, W. E., Witthuhn, B. A., McMickle, A. P., Doherty, P. C., Grosveld, G. C., and Ihle, J. N., Defective lymphoid development in mice lacking Jak3, Science, 270, 800, 1995.
60. Guschin, D., Rogers, N., Briscoe, J., Witthuhn, B., Watling, D., Horn, F., Pellegrini, S., Yasukawa, K., Heinrich, P., Stark, G. R., Ihle, J. N., and Kerr, I. M., A major role for the protein tyrosine kinase JAK1 in the JAK/STAT signal transduction pathway in response to interleukin-6, EMBO J., 14, 1421, 1995.
61. Ihle, J. N., Cytokine receptor signalling, Nature, 377, 591, 1995
62. Daniel, N. N., Pernis, A., and Rothman, P. B., Jak-STAT signaling induced by the v-abl oncogene, Science, 269, 1875, 1995.
63. Fleischman, R. A., From white spots to stem celis: the role of the kit receptor in mammalian development, Trend Gener., 9, 285, 1995.
64. Mucenski, M. L., McLain, K., Kier, A. B., Swerdlow, S. H., Schreiner, C. M., Miller, T. A., Pietryga, D. W., Scott, W. J., Jr., and Potter, S. S., A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis, Cell, 65, 677, 1991.
65. van der Lugt, N. M. T., Domen, J., Linders, K., van Roon, M., Robanus-Maandag, E., te Riele, H., van der Valk, M., Deschamps, J., Sofroniew, M., van Lohuizen, M., and Berns, A., Posterior transformation, neurological abnormalities, and severe hematopoietic defects in mice with a targeted deletion of the bmi-1 proto-oncogene, Genes Dev., 8, 757, 1994.
66. Schwartzberg, P. L., Goff, S. P., and Robertson, E. J., Germ-line transmission of a c-abl mutation produced by targeted gene disruption in ES cells, Science, 246, 799, 1989.
67. Tybulewicz, V. L. J., Crawford, C. E., Jackson, P. K., Bronson, R. T., and Mulligan, R. C., Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene, Cell, 65, 1153, 1991.
68. ml mutation show poor viability and depletion of selected B and T cell populations, Cell, 65, 1165, 1991.
69. Hardin, J. D. Boast, S., Schwarzberg, P. L., Lee, G., Alt, F. W., Stall, A. M., and Goff, S. P., Bone marrow B lymphocyte development in c-abl-deficient mice, Cell. Immunol., 165, 44, 1995.
70. Tsai, F.-Y., Keller, G., Kuo, F. C., Weiss, M., Chen, J., Rosenblatt, M., Alt, F. W., and Orkin, S. H., An early haematopoietic defect in mice lacking the transcription factor GATA-2, Nature, 371, 221, 1994.
71. Scott, E. W., Simon, M. C., Anastasi, J., and Singh, H., Requirement of transcription factor PU. 1 in the development of multiple hematopoietic lineages, Science, 265, 1573, 1994.
72. Bain, G., Maandag, E. C. R., Izon, D. J., Amsen, D., Kruisbeek, A. M., Weintraub, B. C., Krop, I., Schlissel, M. S., Feeney, A. J., van Roon, M., van der Valk, M., te Riele, P. J., Berns, A., and Murre, C., E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements, Cell, 79, 885, 1994.
73. Zhuang, Y., Soriano, P., and Weintraub, H., The helix-loop-helix gene E2A is required for B cell differentiation, Cell, 79, 875, 1994.
74. Urbanek, P., Wang, Z.-Q., Fetka, I., Wagner, E. F., and Busslinger, M., Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax5/BSAP, Cell, 79, 901, 1994.
75. Sun, X.-H., Constitutive expression of the IdI gene impairs mouse B cell development, Cell, 79, 893, 1994.
76. Kirchgessner, C. U., Patil, C. K., Evans, J. W., Cuomo, C. A., Fried, L. M., Carter, T., Oettinger, M. A., and Brown, J. M., DNA-dependent kinase (p350) as a candidate gene for murine SCID defect, Science, 267, 1178, 1995.
77. Lees-Miller, S. P., Godbout, R., Chan, D. W., Weinfeld, M., Day, R. S., III, Barron, G. M., and Allalunis-Turner, J., Absence of p359 subunit of DNA-activated protein kinase from a radiosensitive human cell line, Science, 267, 1183, 1995.
78. Blunt, T., Finnie, N. J., Taccioli, G. E., Smith, G. C. M., Demengeot, J., Gottlieb, T. M., Mizuta, R., Varghese, A. J., Alt, F. W., Jeggo, P. A., and Jackson, S. P., Defective DNA-dependent protein kinase activity is linked to V(D)J recombination and DNA repair defects associated with the murine SCID mutation, Cell, 80, 813, 1995.
79. Mombaerts, P., Iacomini, J., Johnson, R. S., Herrup, K., Tonegawa, S., and Papaioannou, V. E., Rag-1-deficient mice have no mature B and T lymphocytes, Cell, 68, 869, 1992.
80. Shinkai, Y., Rathbun, G., Lam, K.-P., Oltz, E. M., Stewart, V., Mendelsohn, M., Charron, J., Datta, M., Young, F., Stall, A. M., and Alt, F. W., Rag-2-dcficient mice lack mature lymphocytes owing to an inability to initiate V(D)J rearrangement, Cell, 68, 855, 1992.
81. Thomas, J. D., Sideras, P., Smith, C. I. E., Vorechovsky, I., Chapman, V., and Paul, W. E., A missense mutation in the X-linked agammaglobulinemia gene colocalizes with the mouse X-linked immunodeficiency, Science, 261, 355, 1993.
82. Rawlings, D. J., Saffran, D. C., Tsukada, S., Largaespada, D. A., Grimaldi, J. C., Cohen, L., Mohr, R. N., Bazan, J. F., Howard, M., Copeland, N. G., Jenkins, N. A., and Witte, O. N., Mutation of the unique region of Bruton's tyrosine kinase in immunodeficient XID mice, Science, 261, 358, 1993.
83. Kerner, J. D., Appleby, M. W., Mohr, R. N., Chien, S., Rawlings, D. J., Maliszewski, C. R., Witte, O. N., and Perlmutter, R. M., Impaired expansion of mouse B cell progenitors lacking Btk, Immunity, 3, 301, 1995.
84. Khan, W. N., Alt, F. W., Gerstein, R. M., Malynn, B. A., Larsson, I., Rathbun, G., Davidson, L., Müller, S., Kantor, A. B., Herzenberg, L. A., Rosen, F. S., and Sideras, P., Defective B cell development and function in Btk-deficient mice, Immunity, 3, 283, 1995.
85. Smith, C. I. E., Islam, K. B., Vorechovsky, I., Olerup, O., Wallin, E., Rabbani, H., Baskin, B, and Hammarström, L., X-linked agammaglobulinemia and other immunoglobulin deficiencies, Immunol. Rev., 138, 159, 1994.
86. Kitamura, D., Roes, J., Kühn, R., and Rajewsky, K., A B-cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ chain, Nature, 350, 423, 1991.
87. Chen, J., Trounstine, M., Alt, F. W., Young, F., Kurahara, C., Loring, J. F , et al., Immunoglobulin gene rearrangement in B-cell-deficient mice generated by targeted deletion of the JH locus. Int. Immunol., 5, 647, 1993.
88. Jakobovits, A., Vergara, G. J., Kennedy, J. L., Hales, J. F., McGuinness, R. P., Casentini-Borocz, D. E., Brenner, D. G., and Otten, G. R., Analysis of homozygous mutant chimeric mice: deletion of the immunoglobulin heavy-chain joining region blocks B-cell development and antibody production, Proc. Natl. Acad. Sci. U.S.A., 90, 2551, 1993.
89. Kitamura, D., Kudo, A., Schaal, S., Muller, W., Melchers, F., and Rajewsky, K., A critical role of λ5 protein in B cell development, Cell, 69, 823, 1992.
90. Komori, T., Okada, A., Stewart, V., and Alt, F. W., Lack of N regions in antigen receptor variable region genes of TdT-deficient lymphocytes, Science, 261, 1171, 1993.
91. Gilfillan, S., Dierich, A., Lemeur, M., Benoist, C., and Mathis, D., Mice lacking TdT: mature animals with an immature lymphocyte repertoire, Science, 261, 1175, 1993.
92. Chen, J., Trounstine, M., Kurahara, C., Young, F., Kuo, C.-C., Xu, Y., Loring, J. F., Alt, F. W., and Huszar, D., B cell development in mice that lack one or both immunoglobulin κ light chain genes, EMBO J., 12, 821, 1993.
93. Tarakhovsky, A., Turner, M., Schaal, S., Mee, P. V., Duddy, L. P., Rajewsky, K., and Tybulewicz, V. L. J., Defective antigen receptor-mediated proliferation of B and T cells in the absence of vav, Nature, 374, 467, 1995.
94. Zhang, R., Alt, F. W., Davidson, L., Orkin, S. H., and Swat, W., Defective signaling through the T- and B-cell antigen receptors in lymphoid cells lacking the vav protooncogene, Nature, 374, 470, 1995.
95. Zmuidzinas, A., Fischer, K.-D., Lira, S. A., Forrester, L., Bryant, S., Bernstein, A., and Barbacaid, M., The vav protooncogene is required early in embryogenesis but not for hematopoietic development in vitro, EMRO J., 14, 1, 1995.
96. Renshaw, B. R., Fanslow, W. C., III, Armitage, R. J., Campbell, K. A., Liggitt, D., Wright, B., Davison, B. L., and Maliszewski, C. R., Humoral immune responses in CD40 ligand-deficient mice, J. Exp. Med., 180, 1889, 1994.
97. Xu, J., Foy, T. M., Laman, J. D., Elliott, E. A., Dunn, J. J., Waldschmidt, T. J., Elsemore, J., Noelle, R. J., and Flavell, R. A., Mice deficient for the CD40 ligand, Immuniy, 1, 423, 1994.
98. Kawabe, T., Naka, T., Yoshida, K., Tanaka, T., Fujiwara, H., Suematsu, S., Yoshida, N., Kishimoto, T., and Kikutani, H., The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation, Immunity, 1, 167, 1994.
99. Castigli, E., Alt, F. W., Davidson, L., Bottaro, A., Mizoguchi, E., Bhan, A. K., and Geha, R. S., CD40-deficient mice generated by recombination-activating gene-2-deficient blastocyst complementation, Proc. Natl. Acad Sci. U.S.A., 91, 12135, 1994.
100. Rickert, R. C., Rajewsky, K., and Roes, J., Impairment of T-cell-mediated B-cell responses and B-1 cell development in CD19-deficient mice, Nature, 376, 352, 1995.
101. DiSanto, J. P., Müller, W., Guygrand, D., Fischer, A., and Rajewsky, K., Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor γ chain, Proc. Natl. Acad. Sci. U.S.A., 92, 377, 1995.
102. Cao, X., Shores, E. W., Hu-Li, J., Anver, M. R., Kelsall, B. L., Russell, S. M., Drago, J., Noguchi, M., Grinberg, A., Bloom, E. T., Paul, W. E., Katz, S. I., Love, P. E., and Leonard, W. J., Defective lymphoid development in mice lacking expression of the common cytokine receptor γ chain, Immunity. 2, 223, 1995.
103. Corcoran, L. M., Karvelas, M., Nossal, G.J., Ye, J. S., Jacks, T., and Baltimore, D., Oct-2, although not required for early B-cell development, is critical for later B-cell maturation and for postnatal survival, Genes Dev., 7, 570, 1993.
104. Dorshkind, K., Transcriptional control points during lymphopoiesis. Cell, 79, 751, 1994.
105. Allen, R. C., Armitage, R. J., Conley, M. E., Rosenblatt, H., Jenkins, N. A., Copeland, N. G., Bedell, M. A., Edelhoff, S., Disteche, C. M., Simoneaux, D. K., Fanslow, W. C., Belmont, J., and Spriggs, M. K., CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome, Science, 250, 990, 1993.
106. Aruffo, A., Farrington, M., Hollenbaugh, D., Li, X., Milatovich, A., Nonoyama, S., Bajorath, J., Grosmarie, L. S., Stenkamp, R., Neubauer, M., Roberts, R. L., Noelle, R. J., Ledbetter, J. A., Francke, U., and Ochs, H. D., The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome, Cell, 72, 291, 1993.
107. DiSanto, J. P., Bonnefoy, J., Gauchat, J. F., Fischer, A., and de Saint Basile, G., CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM. Nature, 361, 541, 1993.
108. Fuleihan, R., Ramesh, N., Loh, R., Jabara, H., Rosen, F. S., Chatila, T., Fu, S. M., Stamenkovic, L, and Geha, R. S., Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM, Proc. Natl. Acad. Sci. U.S.A., 90, 2170, 1993.
109. Korthäuer, U., Graf, D., Mages, H. W., Briere, F., Padayachee, M., Malcolm, S., Ugazio, A. G., Notarangelo, L. D., Levinsky, R. J., and Kroczek, R. A., Defective expression of the T-cell ligand causes X-linked immunodeficiency with hyper-IgM, Nature, 361, 539, 1993.
110. Zhou, L.-J., Smith, H. M., Waldschmidt, T. J., Schwarting, R., Daley, J., and Tedder, T. F., Tissue-specific expression of the human CD19 gene in transgenic mice inhibits antigen-independent B-lymphocyte development, Mol. Cell. Biol., 14, 3884, 1994.
111. Engel, P., Zhou, L. J., Ord, D. C., Sato, S., Koller, B., and Tedder, T. F., Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule, Immunity, 3, 39, 1995.
112. Veis, D. J., Sorenson, C. M., Shutter, J. R., and Korsmeyer, S. J., Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair, Cell, 75, 229, 1993.
113. Nakayama, K., Nakayama, K.-i., Negishi, I. Kuida, K., Sawa, H., and Loh, D. Y., Targeted disruption of Bcl-2αβ in mice: occurrence of gray hair, polycystic kidney disease, and lymphocytopenia, Proc. Natl. Acad. Sci. U.S.A., 91, 3700, 1994.
114. Motoyama, N., Wang, F., Roth, K. A., Sawa, H., Nakayama, K.-i., Nakayama, K., Negishi, I., Senju, S., Zhang, Q., Fujii, S., and Loh, D. Y., Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice, Science, 267, 1506, 1995.
115. Knudson, C. M., Tung, K. S. K., Tourtellotte, W. G., Brown, G. A., and Korsmeyer, S. J., Baxdeficient mice with lymphoid hyperplasia and male germ cell death, Science, 270, 96, 1995.
116. Cory, S., Regulation of lymphocyte survival by Bcl-2 gene family, Annu. Rev. Immunol., 13, 513, 1995.
117. Roberts, C. W. M., Shutter, J. R., and Korsmeyer, S. J., Hox 11 controls the genesis of the spleen, Nature, 368, 747, 1994.
118. Okada, S., Wang, Z.-Q., Grigoriadis, A. E., Wagner, E. F., and von Rüden, T., Mice lacking c-fos have normal hematopoietic stem cell but exhibit altered B-cell differentiation due to an impaired bone marrow environment, Mol. Cell. Biol., 14, 382, 1994.
119. Resh, M. D., Myristylation and palmitylation of Src family members: the fats of the matter, Cell, 76, 411, 1994.
120. Yurchak, L. K. and Sefton, B. M., Palmitoylation of either Cys-3 or Cys-5 is required for the biological activity of the Lck tyrosine protein kinase, Mol. Cell. Biol., 15, 6914, 1995.
121. Carrera, A. C., Paradis, H., Borlano, L. R., Roberts, T. M., and Martinez-A, C., Lck unique domain influences Lck specificity and biological function, J. Biol. Chem., 270, 3385, 1995.
122. lyn and p59 fyn domains associate with nonphosphorylated and phosphorylated Ig-α, Proc. Natl. Acad. Sci. U.S.A., 91, 4268, 1994.
123. Okada, M., Nada, S., Yamanashi, Y., Yamamoto, T., and Nakagawa, H., CSK: a protein-tyrosine kinase involved in regulation of src family kinases, J. Biol. Chem., 266, 24249, 1991.
124. lck at Tyr-505 and down-regulates its catalytic activity, EMBO J., 2919, 1992.
125. Superti-Furga, G., Fumagalli, S., Koegl, M., Courtneidge, S. A., and Draetta, G., Csk inhibition of Src activity requires both the SH2 and SH3 domains of Src, EMBO J., 12, 2625, 1993.
126. fyn, Mol. Cell. Biol., 14, 6372, 1994.
127. Erpel, T., Superti-Furga, G., and Courtneidge, S. A., Mutational analysis of the Src SH3 domain: the same residues of the ligand binding surface are important for intra- and intermolecular interactions, EMBO J., 14, 963, 1995.
128. Superti-Furga, G. and Courtneidge, S. A., Structure-function relationships in Src family and related protein tyrosine kinases, BioEssays, 17, 321, 1995.
129. Pleiman, C. M., D'Ambrosio, D., and Gambier, J. C., The B-cell antigen receptor complex: structure and signal transduction, Immunol. Today, 15, 393, 1994.
130. Aoki, Y., Kim, Y.-T., Stillwell, T., Kim, T. J., and Pillai, S., The SH2 domains of Src family kinases associate with Syk, J. Biol. Chem., 270, 15658, 1995.
131. Sidorenko, S. P., Law, C.-L., Chandran, K. A., and Clark, E. A., Human spleen tyrosine kinase p72Syk associates with the Src-family kinase p53/p56Lyn and a 120-kDa phosphoprotein, Proc. Natl. Acad. Sci. U.S.A., 92, 359, 1995.
132. Clark, M. R., Johnson, S. A., and Gambier, J. C., Analysis of Ig-α tyrosine kinase interaction reveals two levels of binding specificity and tyrosine phosphorylated Ig-α stimulation of Fyn activity, EMBO J., 13, 1911, 1994.
133. Flaswinkel, H. and Reth, M., Dual role of the tyrosine activation of the Ig-α protein during signal transduction via the B cell antigen receptor, EMBO J., 13, 83, 1994.
134. Scharenberg, A. M., Lin, S., Cuenod, B., Yamamura, H., and Kinet, J.-P., Reconstitution of interactions between tyrosine kinases and the high-affinity IgE receptor that are controlled by receptor clustering, EMBO J., 14, 3385, 1995.
135. Kurosaki, T., Takata, M., Yamanashi, Y., Inazu, T., Taniguchi, T., Yamamoto, T., and Yamamura, H., Syk activation by the Src-family tyrosine kinase in the B cell receptor signaling, J. Exp. Med., 179, 1725, 1994.
136. Saouaf, S. J., Mahajan, S., Rowley, R. B., Kut, S. A., Fargnoli, J., Burkhardt, A. L., Tsukada, S., Witte, O. N., and Bolen, J. B., Temporal differences in the activation of three classes of nontransmembrane protein tyrosine kinases following B-cell antigen receptor surface engagement, Proc. Natl. Acad. Sci. U.S.A., 91, 9524, 1994.
137. Iwashima, M., Irving, B. A., van Oers, N. S. C., Chan, A. C., and Weiss, A., Sequential interactions of the TCR with two distinct cytoplasmic tyrosine kinases, Science, 263, 1136, 1994.
138. Ting, A. T., Dick, C. J., Schoon, R. A., Karnitz, L. M., Abraham, R. T., and Leibson, P. J., Interaction between lck and syk family tyrosine kinase in Fcψ receptor-initiated activation of natural killer cells, J. Biol. Chem., 270, 16415, 1995.
139. Mahajan, S., Fargnoli, J., Burkhardt, A. L., Kut, S. A., Saouaf, S. J., and Bolen, J. B., Src family protein tyrosine kinases induce autoactivation of Bruton's tyrosine kinase, Mol. Cell Biol., 15, 5304, 1995.
140. Chardin, P., Cussac, D., Maignan, S., and Ducruix, A., The Grb2 adaptor, FEBS Lett., 369, 47, 1995.
141. Waksman, G., Kominos, D., Robertson, S. C., Pant, N., Baltimore, D., Birge, R. B., Cowburn, D., Hanafusa, H., Mayer, B. J., Overduin, M., Resh, M. D., Rios, C. B., Silverman, L., and Kuriyan, J., Crystal structure of the phosphotyrosine recognition domain SH2 of v-src complexed with tyrosine-phosphorylated peptides, Nature, 358, 646, 1992.
142. Waksman, G., Shoelson, S. E., Pant, N., Cowburn, D., and Kuriyan, J., Binding of a high-affinity phosphotyrosyl peptide to the Src SH2 domain; crystal structures of the complexed and peptide-free forms, Cell, 72, 779, 1993.
143. c-src SH2 domain complexed with a phosphorylated tyrosine pentapeptide, Biochemistry, 34, 2107, 1995.
144. lck, Nature, 362, 87, 1993.
145. Eck, M. J., Atwell, S. K., Shoelson, S. E., and Harrison, S. C., Structure of the regulatory domains of the Src-family tyrosine kinase Lck, Nature, 368, 764, 1994.
146. lck complexed with two phosphopeptides suggest a gated peptide binding site, J. Mol. Biol., 246, 344, 1995.
147. Piccione, E., Case, R. D., Domchek, S. M., Hu, P., Chaudhuri, M., Backer, J. M., Schlessinger, J., and Shoelson, S. E., Phosphatidylinositol 3-kinase p85 SH2 domain specificity defined by direct phosphopeptide/SH2 domain binding, Biochemistry, 32, 3197, 1993.
148. Songyang, Z., Shoelson, S. E., Chaudhuri, M., Gish, G., Pawson, T., Haser, W. G., King, F., Roberts, T., Ratnofsky, S., Lechleider, R. J., Neel, B. G., Birge, R. B., Fajardo, J. E., Chou, M. M., Hanafusa, H., Schaffhausen, B., and Cantley, L. C., SH2 domains recognize specific phosphopeptide sequences, Cell, 72, 767, 1993.
149. Songyang, Z., Shoelson, S. E., McGlade, J., Olivier, P., Pawson, T., Bustelo, X. R., Barbacid, M., Sabe, H., Hanafusa, H., Yi, T., Ren, R., Baltimore, D., Ratnofsky, S., Feldman, R. A., and Cantley, L. C., Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav, Mol. Cell. Biol., 14, 2777, 1994.
150. Case, R. D., Piccione, E., Wolf, G., Benett, A. M., Lechleider, R. J., Neel., B. G., and Shoelson, S. E., SH-PTP2/Syp SH2 domain binding specificity is defined by direct interactions with platelet-derived growth ctor β-receptor, epidermal growth factor receptor, and insulin receptor substrate-1-derived phospho-peptides. J. Biol. Chem., 269, 10467, 1994.
151. von Bonin, A., Wienands, J., Manning, U., Zuber, J. F., and Baumann, G., The βD-sheet residues of the Lck-derived SH2 domain determine specificity in the interaction with tyrosine-phosphorylated ligands in Ramos B cells, J. Biol. Chem., 269, 33035, 1994.
152. syk through physical association and N-terminal tyrosine phosphorylation, Mol. Cell. Biol., 14, 5249, 1994.
153. Aoki, Y., Isselbacher, K. J., Cherayil, B. J., and Pillai, S., Tyrosine phosphorylation of Blk and Fyn Src homology 2 domain-binding proteins occurs in response to antigen-receptor ligation in B cells and constitutively in pre-B cells, Proc. Natl. Acad Sci. U.S.A., 91, 4204, 1994.
154. lck regulates specificity of its Src homology 2 domain, Proc. Natl. Acad. Sci. U.S.A., 92, 5778, 1995.
155. Yu, H., Rosen, M. K., Shin, T. B., Seidel-Dugan, C., Brugge, J. S., and Schreiber, S. L., Solution structure of the SH3 domain of Src and identification of its ligand-binding site, Science, 258, 1665, 1992.
156. Noble, M. E. M., Musacchio, A., Saraste, M., Courtneidge, S. A., and Wierenga, R. K., Crystal structure of the SH3 domain in human Fyn; comparison of the three-dimensional structures of SH3 domains in tyrosine kinases and spectrin, EMBO J., 12, 2617, 1993.
157. Musacchio, A., Saraste, M., and Wilmanns, M., High-resolution crystal structures of tyrosine kinase SH3 domains complexed with proline-rich peptides, Nature Struct. Biol., 1, 546, 1994.
158. Borchert, T. V., Mathieu, M., Zeelen, J. Ph., Courtneidge, S. A., and Wierenga, R. K., The crystal structure of human CskSH3: structural diversity near the RT-Src and n-Src loop, FEBS Lett., 341, 79, 1994.
159. Feng, S., Chen, J. K., Yu, H., Simon, J. A., and Schreiber, S. L., Two binding orientations for peptides to the Src SH3 domain: development of a general model for SH3-ligand interactions, Science, 266, 1241, 1994.
160. Abrams, C. S. and Zhao, W., SH3 domains specifically regulate kinase activity of expressed Src family proteins, J. Biol. Chem., 270, 333, 1995.
161. SYK expressed in hematopoietic cells, Cell. Sign., 7, 185, 1995.
162. Rowley, R. B., Burkhardt, A. L., Chao, H.-G., Matsueda, G. R., and Bolen, J. B., Syk protein-tyrosine kinase is regulated by tyrosine-phosphoryted Igα/Igβ immunorecptor tyrosine activation motif binding and autophosphorylation, J. Biol. Chem., 270, 11590, 1995.
163. 2+ mobilization through distinct pathways, EMBO J., 13, 1341, 1994.
164. syk with the src homology-2 (SH2) domains of PLCγ1 in B lymphocytes, J. Biol. Chem., 270, 11806, 1995.
165. Kihara, H. and Siraganian, R. P., Src homology 2 domains of Syk and Lyn bind to tyrosine-phosphorylated subunit of high affinity IgE receptor, J. Biol. Chem., 269, 22427, 1994.
166. Narula, S. S., Yuan, R. W., Adams, S. E., Green, O. M., Green, J., Philips, T. B., Zydowsky, L. D., Botfieid, M. C., Hatada, M., Laird, E. R., Zoller, M. J., Karas, J. L., and Dalgarno, D. C., Solution structure of the C-terminal SH2 domain of the human tyrosine kinase Syk complexed with a phosphotyrosine pentapepetide, Structure, 3, 1061, 1995.
167. Koyasu, S., Tse, A. G. D., Moingeon, P., Hussey, R. E., Mildonian, A., Hannisian, J., Clayton, L. K., and Reinherz, E. L., Delineation of a T-cell activation motif required for binding of protein tyrosine kinases containing tandem SH2 domains, Proc. Natl. Acad. Sci. U.S.A., 91, 6693, 1994.
168. Letourneur, F. and Klausner, R. D., T-cell and basophil activation through the cytoplasmic tail of T-cell-receptor ζ family proteins, Proc. Natl. Acad. Sci. U.S.A., 88, 8905, 1995.
169. Cussac, D., Rech, M., and Chardin, P., Binding of the Grb2 SH2 domain to phosphotyrosine motifs does not change the affinity of its SH3 domains for Sos proline-rich motifs, EMBO J., 13, 4011, 1994.
170. Simon, J. A. and Schreiber, S. L., Grb2 SH3 binding to peptides from SOS - evaluation of a general model for SH3-ligand interactions, Chem. Biol., 2, 53, 1995.
171. Terasawa, H., Kohda, D., Hatanaka, H., Tsuchiya, S., Ogura, K., Nagata, K., Ishii, S., Mandiyan, V., Ullrich, A., Schlessinger, J., and Inagaki, F., Structure of the N-terminal SH3 domain of GRB2 complexed with a peptide from the guanine nucleotide releasing factor Sos, Nature Struct. Biol., 1, 891, 1994.
172. Goudreau, N., Cornille, F., Duchesne, M., Parker, F., Tocqué, B., Garbay, C., and Roques, B. P., NMR structure of the N-terminal SH3 domain of GRB2 and its complex with a proline-rich peptide from Sos, Nature Struct. Biol., 1, 898, 1994.
173. Wittekind, M., Mapelli, C., Farmer, B. T., Suen, K.-L., Goldfarb, V., Tsao, J., Lavoie, T., Barbacid, M., Meyers, C. A., and Mueller, L., Orientation of peptide fragments from Sos proteins bound to the N-terminal SH3 domain of Grb2 determined by NMR spectroscopy, Biochemistry, 33, 13531, 1994.
174. Maignan, S., Guilloteau, J.-P., Fromage, N., Arnoux, B., Becquart, J., and Ducruix, A., Crystal structure of the mammalian Grb2 adaptor, Science, 268, 291, 1995.
175. Kohda, D., Terasawa, H., Ichikawa, S., Ogura, K., Hatanaka, H., Mandiyan, V., Ullrich, A., Schlessinger, J., and Inagaki, F., Solution structure and ligand-binding site of the carboxy-terminal SH3 domain of GRB2, Structure, 2, 1029, 1994.
176. Mano, H., Mano, K., Tang, B., Koehler, M., Yi, T., Gilbert, D. J., Jenkins, N. A., Copeland, N. G., and Ihle, J. N., Expression of novel form of Tec kinase in hematopoietic cells and mapping the gene to chromosome 5 near Kit, Oncogene, 8, 417, 1993.
177. Siliciano, J. D., Morrow, T. A., and Desiderio, S. V., itk, a T-cell-specific tyrosine kinase gene inducible by interleukin 2, Proc. Natl. Acad. Sci. U.S.A., 89, 11194, 1992.
178. Tamagnone, L., Lahtinen, I., Mustonen, T., Virtaneva, K., Francis, F., Muscatelli, F., Alitalo, R., Smith, C. I. E, Larsson, C., and Alitalo, K., BMX, a novel nonreceptor tyrosine kinase gene of the BTK/ITK/TEC/TXK family located in chromosome Xp22.2, Oncogene, 9, 3683, 1994.
179. Vihinen, M., Nilsson, L., and Smith, C. I. E., Tec homology (TH) adjacent to the PH domain, FEBS Lett., 350, 263, 1994.
180. Vihinen, M., Cooper, M. D., de Saint Basile, G., Fischer, A., Good, R. A., Hendriks, R. W., Kinnon, C., Kwan, S.-P., Litman, G. W., Notarangelo, L. D., Ochs, H. D., Rosen, F. S., Vetrie, D., Webster, A. D. B., Zegers, B. J. M., and Smith, C. I. E., BTKbase: a database of XLA causing mutations, Immunol. Today, 16, 460, 1995.
181. Vihinen, M., Iwata, T., Kinnon, C., Kwan, S.-P., Ochs, H. D., Vorechovsky, I, and Smith, C. I. E., BTKbase, mutation database for X-linked agammaglobulinemia, Nucl. Acids Res., 24, 160, 1996.
182. Mattsson, P., Vihinen, M., Nilsson, L., and Smith, C. I. E., X-linked agammaglobulinemia (XLA): a genetic tyrosine kinase (Btk) disease, Bioessays, in press.
183. Yao, L., Kawakami, Y., and Kawakami, T., The pleckstrin homology domain of Bruton tyrosine kinase interacts with protein kinase C. Proc. Natl. Acad. Sci. U.S.A., 91, 9175, 1994.
184. Touhara, K., Inglese, J., Pitcher, J. A., Shaw, G., and Lefkowitz, R. J., Binding of G protein βγ-subunits to pleckstrin homology domains, J. Biol. Chem., 269, 10217, 1994.
185. Cheng, C., Ye, Z.-S., and Baltimore, D., Binding of Bruton's tyrosine kinase to Fyn, Lyn, or Hck through a Src homology 3 domain-mediated interaction, Proc. Natl. Acad. Sci. U.S.A., 91, 8152, 1994.
186. Cory, G. O. C., Levering, R. C., Hinshelwood, S., MacCarthy-Morrogh, L., Levinski, R. J., and Kinnon, C., The protein product of the c-cbl protooncogene is phosphorylated after B cell receptor stimulation and binds the SH3 domain of Bruton's tyrosine kinase, J. Exp. Med., 182, 611, 1995.
187. Aoki, Y., Isselbacher, K. J., and Pillai, S., Bruton tyrosine kinase is tyrosine phosphorylated and activated in pre B lymphocytes and receptor-ligated B cells, Proc. Natl. Acad. Sci. U.S.A., 91, 10606, 1994.
188. de Weers, M., Brouns, G. S., Hinshelwood, S., Kinnon, C., Schuurman, R. K. B., Henkriks, R. W., and Borst, J., B-cell antigen receptor stimulation activates the human Bruton's tyrosine kinase, which is deficient in X-linked agammaglobulinemia, J. Biol. Chem., 269, 23857, 1994.
189. Hinshelwood, S., Lovering, R. C., Genevier, H. C., Levinsky, R. J., and Kinnon, C., The protein defective in X-linked agammaglobulinemia, Bruton's tyrosine kinase, shows increased autophosphorylation activity in vitro when isolated from cells in which the B cell receptor has been cross-linked, Eur. J. Immunol., 25, 1113, 1995.
190. Kawakami, Y., Yao, L., Miura, T., Tsukada, S., Witte, O. N., and Kawakami, T., Tyrosine phosphorylation and activation of Bruton tyrosine kinase upon FceRI cross-linking, Mol. Cell. Biol., 14, 5108, 1994.
191. Matsuda, T., Takahashi-Tezuka, M., Fukada, T., Okuyama, Y., Fujitani, Y., Tsukada, S., Mano, H., Hirai, H., Witte, O. N., and Hirano, T., Association and activation of Btk and Tec tyrosine kinases by gp130, a signal transducer of the interleukin-6 family of cytokines, Blood, 85, 627, 1995.
192. Sato, S., Katagiri, T., Takaki, S., Kikuchi, Y., Hitoshi, Y., Yonehara, S., Tsukada, S., Kitamura, D., Watanabe, T., Witte, O., and Takatsu, K., IL-5 receptor-mediated tyrosine phoshorylation of SH2/ SH3-containing proteins and activation of Bruton's tyrosine and Janus 2 kinases, J. Exp. Med., 180, 2101, 1994.
193. Koike, M., Kikuchi, Y., Tominaga, A., Takaki, S., Akagi, K., Miyazaki, J.-i., Yamamura, K.-i., and Takatsu, K., Defective IL-5-receptor-mediated signaling in B cells and of X-linked immunodeficient mice, Int. Immunol., 7, 21, 1995.
194. Santos-Argumedo, L., Lund, F. E., Heath, A. W., Soivason, N., Wu, W. W., Grimaldi, J. C., Parkhouse, R. M. E., and Howard, M., CD38 unresponsiveness of xid B cells implicates Brutons's tyrosine kinase (btk) as a regulator of CD38-induced signal transduction, Int. Immunol., 7, 163, 1995.
195. Ohta, Y., Haire, R. N., Litman, R. T., Fu, S. M., Nelson, R. P., Kratz, J., Kornfeld, S. J., de la Morena, M., Good, R. A., and Litman, G. W., Genomic organization and structure of Bruton agammaglobulinemia tyrosine kinase: localization of mutations associated with varied clinical presentations and course in X-chromosome-linked agammaglobulinemia, Proc. Natl. Acad. Sci. U.S.A., 91, 9062, 1994.
196. Hagemann, T. L., Chen, Y., Rosen, F. S., and Kwan, S.-P., Genomic organization of the Btk gene and exon scanning for mutations in patients with X-linked agammaglobulinemia, Hum. Mol. Genet., 3, 1743, 1994.
197. Sideras, P., Müller, S., Shiels, H., Jin, H., Khan, W. N., Nilsson, L., Parkinson, E., Thomas, J. D., Brandén, L., Larsson, I., Paul, W. E., Rosen, F. S., Alt, F. W., Vetrie, D., Smith, C. I. E., and Xanthopoulos, K. G., Genomic organization of mouse and human Bruton's agammaglobulinemia tyrosine kinase (Btk) loci, J. Immunol., 153, 5607, 1994.
198. Rohrer, J., Parolino, O., Belmont, J. W., and Conley, M. E., The genomic structure of human Btk, the defective gene in X-linked agammaglobulinemia, Immunogenetics, 40, 319, 1994.
199. Zhu, Q., Zhang, M., Rawlings, D. J., Vihinen, M., Hageman, T., Saffran, D. C., Kwan, S.-P., Nilsson, L., Smith, C. I. E., Witte, O. N., Chen, S.-H., and Ochs, H. D., Deletion within the Src homology domain 3 of Bruton's tyrosine kinase resulting in X-linked agammaglobulinemia (XLA), J. Exp. Med., 180, 461, 1994.
200. Vihinen, M., Vetrie, D., Maniar, H. S., Ochs, H. D., Zhu, Q., Vorechovsky, I., Webster, A. D. B., Notarangelo, L. D., Nilsson, L., Sowadski, J. M., and Smith, C. I. E., Structural basis for chromosome X-linked agammaglobulinemia: a tyrosine kinase disease, Proc. Natl. Acad. Sci. U.S.A., 91, 12803, 1994.
201. Vihinen, M., Nilsson, L., and Smith, C. I. E., Structural basis of SH2 domain mutations in X-linked agammaglobulinemia, Biochem. Biophys. Res. Commun., 205, 1270, 1994.
202. Vorechovsky, I., Vihinen, M., de Saint Basile, G., Honsová, S., Hammarstöm, L., Müller, S., Nilsson, L., Fischer, A., and Smith, C. I. E., DNA-based mutation analysis of Bruton's tyrosine kinase gene in patients with X-linked agammaglobulinemia, Hum. Mol. Genet., 4, 51, 1995.
203. Vihinen, M., Zvelebil, M. J. J. M., Zhu, Q., Brooimans, R. A., Ochs, H. D., Zegers, B. J. M., Nilsson, L., Waterfield, M. D., and Smith, C. I. E., Structural basis for pleckstrin homology domain mutations in X-linked agammaglobulinemia, Biochemistry, 34, 1475, 1995.
204. Jin, H., Webster, A. D. B., Vihinen, M., Sideras, P., Vorechovsky, I., Hammarström, L., Bernatowska-Matuszkiewicz, E., Smith, C. I. E., Bobrow, M., and Vetrie, D., Identification of Btk mutations in 20 unrelated patients with X-linked agammaglobulinemia (XLA), Hum. Mol. Genet, 4, 693, 1995.
205. Haslam, R. J., Koide, H. B., and Hemmings, B. A., Pleckstrin domain homology, Nature, 363, 309, 1993.
206. Mayer, B. J., Ren, R., Clark, K. L., and Baltimore, D., A putative modular domain present in diverse signaling proteins, Cell, 73, 629, 1993.
207. Shaw, G., Identification of novel pleckstrin homology (PH) domains provides a hypothesis for PH domain function, Biochem. Biophys. Res. Commun., 195, 1145, 1993.
208. Musacchio, A., Gibson, T., Rice, P., Thompson, J., and Saraste, M., The PH domain: a common piece in the structural patchwork of signaling proteins, Trends Biochem. Sci., 18, 343, 1993.
209. Gibson,T. J., Hyvönen, M., Musacchio, A., Saraste, M., and Birney, E., PH domain: the first anniversary, Trends Biochem. Sci., 19, 349, 1994.
210. Yoon, H. S., Hajduk, P. J., Petros, A. M., Olejniczak, E. T., Meadows, R. P., and Fesik, S. W., Solution stucture of a pleckstrin-homology domain, Nature, 369, 672, 1994.
211. Zhang, P., Talluri, S., Deng, H., Branton, D., and Wagner, G., Solution structure of the pleckstrin homology domain of Drosophila β-spectrin, Structure, 3, 1185, 1995.
212. Macias, M. J., Musacchio, A., Ponstingl, H., Nilges, M., Saraste, M., and Oschkinat, H., Structure of the pleckstrin homology domain from β-spectrin, Nature, 363, 675, 1994.
213. Downing, A. K., Driscoll, P. C., Gout, I., Salim, K., Zvelebil, M. J., and Waterfield, M. D., Three-dimensional solution structure of the pleckstrin homology domain from dynamin, Curr. Biol., 4, 884, 1994.
214. Fushman, D., Cahill, S., Lemmon, M. A., Schlessinger, J., and Cowburn, D., Solution structure of pleckstrin homology domain of dynamin by heteronuclear NMR spectroscopy, Proc. Natl. Acad. Sci. U.S.A., 92, 816, 1995.
215. Timm, D., Salim, K., Gout, I., Guruprasad, L., Waterfield, M., and Blundell, T., Crystal structure of the pleckstrin homology domain from dynamin, Nature Struct. Biol., 1, 782, 1994.
216. Ferguson, K. M., Lemmon, M. A., Schlessinger, J., and Sigler, P. B., Crystal structure at 2.2 Å resolution of the pleckstrin homology domain from human dynamin, Cell, 79, 199, 1994.
217. Harlan, J. E., Hajduk, P. J., Yoon, H. S., and Fesik, S. W., Pleckstrin homology domains bind to phosphatidylinositol-4,5-bisphosphate, Nature, 371, 168, 1994.
218. Hyvönen, M., Macias, M. J., Nilges, M., Oschkinat, H., Saraste, M., and Wilmanns, M., Structure of the binding site for inositol phosphates in a PH domain, EMBO J., 14, 4676, 1995.
219. Harlan, J. E., Yoon, H. S., Hajduk, P. J., and Fesik, S. W., Structural characterization of the interaction between a pleckstrin homology domain and phosphatidylinositol 4,5-bisphosphate, Biochemistry, 34, 9859, 1995.
220. Cifuentes, M. E., Honkanen, L., and Rebecchi, M. J., Proteolytic fragments of phosphoinositide specific phsopholipase C-δ. Catalytic and membrane binding properties, J. Biol. Chem., 268, 11586, 1993.
221. de Weers, M., Mensink, R. G. J., Kraakman, M. E. M., Schuurman, R. K. B., and Hendriks, R. W., Mutation analysis of the Bruton's tyrosine kinase gene in X-linked agammaglobulinemia: identification of a mutation that affects the same codon as is altered in immunodeficient xid mice, Hum. Mol. Genet., 3, 161, 1994.
222. Li, T, Tsukada, S., Satterthwaite, A., Havlik, M. H., Park, H., Takatsu, K., and Witte, O. N., Activation of Bruton's tyrosine kinase (BTK) by a point mutation in its pleckstrin homology (PH) domain, Immunity, 2, 451, 1995.
223. Konishi, H., Kuroda, S., and Kikkawa, U., The pleckstrin homology domain of RAC protein kinase associates with the regulatory domain of protein kinase C ζ, Biochem. Biophys. Res. Commun., 205, 1770, 1994.
224. Koch, W. J., Inglese, J., Stone, W. C., and Lefkowitz, R. J., The binding site for the βγ subunits of terotrimeric G proteins on the β-adrenergic receptor kinase, J. Biol. Chem., 268, 8256, 1993.
225. βγ subunits, Biochemistry, 34, 9111, 1995.
226. βγ and phosphatidylinositol 4,5-bisphosphate binding, J. Biol. Chem., 270, 17000, 1995.
227. Langhans-Rajasekaran, S. A., Wan, Y., and Huang, X.-Y., Activation of Tsk and Btk kinases by G protein βγ subunits, Proc. Natl. Acad. Sci. U.S.A., 92, 8601, 1995.
228. Wang, D.-S., Shaw, R., Winkelmann, J. C., and Shaw, G., Binding of PH domains of β-adrenergic receptor kinase and β-spectrin to WD40/β-transducin repeat containing regions of the β-subunit of trimeric G-proteins, Biochem. Biophys. Res. Commun., 203, 29, 1994.
229. Wang, D.-S., Shaw, R., Hattori, M., Arai, H., Inoue, K., and Shaw, G., Binding of pleckstrin homology domains to WD40/β-transducin repeat containing segments of the protein product of the Lis-1 gene, Biochem. Biophys. Res. Commun., 209, 622, 1995.
230. McCollam, L., Bonfini, L., Karlovich, C. A., Conway, B. R., Kozma, L. M., Banerjee, U., and Czech, M. P., Functional roles for the pleckstrin and Dbl homology regions in the Ras exchange factor Son-of-sevenless, J. Biol. Chem., 270, 15954, 1995.
231. Tsukada, S., Simon, M. I. Witte, O. N., and Katz, A., Binding of βγ subunits of heterotrimeric G proteins to the PH domain of Bruton tyrosine kinase, Proc. Natl. Acad. Sci. U.S.A., 91, 11256, 1994.
232. Abrams, C. S., Wu, H., Zhao, W., Belmonte, E., White, D., and Brass, L. F., Pleckstrin inhibits phosphoinositide hydrolysis initiated by G-protein coupled and growth factor receptors. A role for pleckstrin's PH domains, J. Biol. Chem., 270, 14485, 1995.
233. Alexandropoulos, K., Cheng, G., and Baltimore, D., Proline-rich sequences that bind to Src homology 3 domains with individual specificities, Proc. Natl. Acad. Sci. U.S.A., 92, 3110, 1995.
234. Mano, H., Sato, K., Yazaki, Y., and Hirai, H., Tec protein-tyrosine kinase directly associates with Lyn protein-tyrosine kinase through its N-terminal unique domain, Oncogene, 9, 3205, 1994.
235. Machide, M., Mano, H., and Todokoro, K., Interleukin 3 and erythropoietin induce association of Vav with Tec kinase through Tec homology domain, Oncogene, 11, 619, 1995.
236. Yang, W., Malek, S. N., and Desiderio, S., An SH3-binding site conserved in Bruton's tyrosine kinase and related tyrosine kinases mediates specific protein inractions in vitro and in vivo, J. Biol. Chem., 270, 20832, 1995.
237. Caspar, H. B., Bradley, L. A. D., Katz, F., Levering, R. C., Roifman, C. M., Morgan, G., Levinsky, R. J., and Kinnon, C., Mutation analysis in Bruton's tyrosine kinase, the X-linked agammaglobulinaemia gene, including identification of an insertional hotspot, Hum. Mol. Genet., 4, 755, 1995.
238. Knighton, D. R., Zheng, J., Ten Eyck, L. F., Ashford, V. A., Xuong, N.-H., Taylor, S. S., and Sowadski, J. M., Crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase, Science, 253, 407, 1991.
239. Knighton, D. R., Zheng, J., Ten Eyck, L. F., Xuong, N.-H., Taylor, S. S., and Sowadski, J. M., Structure of a peptide inhibitor bound to the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase, Science, 253, 414, 1991.
240. Knighton, D. R., Bell, S. M., Zheng, J., Ten Eyck, L. F., Xuong, N.-H., Taylor, S. S., and Sowadski, J. M., 2.0 Å refined crystal structure of the catalytic subunit of cAMP-dependent protein kinase complexed with a peptide inhibitor and detergent, Acta Cryst., D49, 357, 1993.
241. Zheng, J., Trafny, E. A., Knighton, D. R., Xuong, N.-H., Taylor, S. S., Ten Eyck, L. F., and Sowadski, J. M., 2.2 Å refined crystal structure of the catalytic subunit of cAMP-dependent protein kinase complexed with MnATP and peptide inhibitor. Acta Cryst., D49, 362, 1993.
242. 2+ adenylyl imidodiphosphate and inhibitor peptide PKI(5-24), EMBO J., 12, 849, 1993.
243. De Bondt, H. L., Rosenblatt, J., Jancarik, J., Jones, H. D., Morgan, D. O., and Kim, S.-H., Crystal structure of cyclin-dependent kinase 2, Nature, 363, 595, 1993.
244. Zhang, F., Strand, A., Robbins, D., Cobb, M. H., and Goldsmith, E. J., Atomic structure of the MAP kinase ERK2 at 2.3 Å resolution, Nature, 367, 704, 1994.
245. Hu, S.-H., Parker, M. W., Lei, J. Y., Wilce, M. C. J., Benian, G. M., and Kemp, B. E., Insights into autoregulation from the crystal structure of twitchin kinase, Nature, 369, 581, 1994.
246. Xu, R.-M., Carmel, G., Sweet, R. M., Kuret, J., and Cheng, X., Crystal structure of casein kinase-1, a phosphate-directed protein kinase, EMBO J., 14, 1015, 1995.
247. Hubbard, S. R., Wei, L., Ellis, L., and Hendrickson, W. A., Crystal structure of the tyrosine kinase domain of the human insulin receptor, Nature, 372, 746, 1995.
248. Hanks, S. K., Eukaryotic protein kinases. Curr. Opin. Struct. Biol., 1, 369, 1991.
249. Zheng, J., Knighton, D. R., Ten Eyck, L. F., Karlsson, R., Xuong, N.-H., Taylor, S. S., and Sowadski, J. M., Crystal structure of the catalytic subunit of cAMP-dependent protein kinase complexed with MgATP and peptide inhibitor, Biochemistry, 32, 2154, 1993.
250. Madhusudan, Trafny, E. A., Xuong, N.-h., Adams, J. A., Ten Eyck, L. F., Taylor, S. S., and Sowadski, J. M., cAMP-dependent protein kinase: crystallographic insights into substrate recognition and phosphotransfer, Prot. Sci., 3, 176, 1994.
251. Cox, S., Radzio-Andzelm, E., and Taylor, S. S., Domain movements in protein kinases, Curr. Opin. Struct. Biol., 4, 893, 1994.
252. Ho, M.-f., Bramson, H. N., Hansen, D. E., Knowles, J. R., and Kaiser, E. T., Stereochemical course of the phospho group transfer catalyzed by cAMP-dependent protein kinase, J. Am. Chern. Soc., 110, 2680, 1988.
253. Taylor, S. S. and Radzio-Andselm, E., Three protein kinase structures define a common motif, Structure, 2, 345, 1994.
254. Maniar, H. S., Vihinen, M., Webster, A. D. B., Nilsson, L., and Smith, C. I. E., Structural basis for X-linked agammaglobulinemia (XLA). Mutations at interacting Btk residues R562, W563 and R582, Clin. Immunol. Immunopathol., 76, S198, 1995.